img

Global Biosimilar Insulin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Biosimilar Insulin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Biosimilar insulin is a biological copy of an original insulin and there is increasing interest in developing and using them. Biosimilar insulins (hereafter called biosimilars or follow-on biologics) are designed to be highly similar to the original, or reference, insulin product described in a patent. They are analogous to generic versions of small-molecule drugs and are developed by companies other than the reference product's patent holder. Producers of biosimilars use manufacturing techniques that are similar, but likely not identical to, those used by the original patent holder. Thus, although a biosimilar and its reference insulin product will have the same amino acid sequence, they may differ slightly in their more subtle molecular characteristics and clinical profiles.
Biosimilar Insulin report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biosimilar Insulin market is projected to reach US$ 6548.3 million in 2034, increasing from US$ 2558 million in 2022, with the CAGR of 14.2% during the period of 2024 to 2034. Demand from Hospital and Retail Pharmacy are the major drivers for the industry.
Global Biosimilar Insulin key players include Biocon, Gan&Lee, Wockhardt, Eli Lilly, Sanofi etc. Global top three players hold a share over 70%. India is the largest market, with a share about 30%, followed by Southeast Asia and China, both have a share about 40 percent
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Biosimilar Insulin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Distribution Channel and Regions Listed in the Report



By Company


Eli Lilly
Sanofi
Gan&Lee
Tonghua Dongbao
United Laboratory
Geropharm
Biocon
Wockhardt
Segment by Type
Biosimilar Insulin Glargine
Biosimilar Insulin Lispro
Other
Segment by Distribution Channel
Hospital
Retail Pharmacy
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biosimilar Insulin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Biosimilar Insulin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Biosimilar Insulin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Biosimilar Insulin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Distribution Channel, Volume and Revenue analysis of Each Distribution Channel in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Biosimilar Insulin introduction, etc. Biosimilar Insulin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Biosimilar Insulin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Biosimilar Insulin Market Overview
1.1 Biosimilar Insulin Product Overview
1.2 Biosimilar Insulin Market Segment by Type
1.2.1 Biosimilar Insulin Glargine
1.2.2 Biosimilar Insulin Lispro
1.2.3 Other
1.3 Global Biosimilar Insulin Market Size by Type
1.3.1 Global Biosimilar Insulin Market Size Overview by Type (2018-2034)
1.3.2 Global Biosimilar Insulin Historic Market Size Review by Type (2018-2024)
1.3.3 Global Biosimilar Insulin Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Biosimilar Insulin Sales Breakdown by Type (2018-2024)
1.4.2 Europe Biosimilar Insulin Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Biosimilar Insulin Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Biosimilar Insulin Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Biosimilar Insulin Sales Breakdown by Type (2018-2024)
2 Global Biosimilar Insulin Market Competition by Company
2.1 Global Top Players by Biosimilar Insulin Sales (2018-2024)
2.2 Global Top Players by Biosimilar Insulin Revenue (2018-2024)
2.3 Global Top Players by Biosimilar Insulin Price (2018-2024)
2.4 Global Top Manufacturers Biosimilar Insulin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Biosimilar Insulin Market Competitive Situation and Trends
2.5.1 Biosimilar Insulin Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Biosimilar Insulin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biosimilar Insulin as of 2022)
2.7 Date of Key Manufacturers Enter into Biosimilar Insulin Market
2.8 Key Manufacturers Biosimilar Insulin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Biosimilar Insulin Status and Outlook by Region
3.1 Global Biosimilar Insulin Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Biosimilar Insulin Historic Market Size by Region
3.2.1 Global Biosimilar Insulin Sales in Volume by Region (2018-2024)
3.2.2 Global Biosimilar Insulin Sales in Value by Region (2018-2024)
3.2.3 Global Biosimilar Insulin Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Biosimilar Insulin Forecasted Market Size by Region
3.3.1 Global Biosimilar Insulin Sales in Volume by Region (2024-2034)
3.3.2 Global Biosimilar Insulin Sales in Value by Region (2024-2034)
3.3.3 Global Biosimilar Insulin Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Biosimilar Insulin by Distribution Channel
4.1 Biosimilar Insulin Market Segment by Distribution Channel
4.1.1 Hospital
4.1.2 Retail Pharmacy
4.1.3 Others
4.2 Global Biosimilar Insulin Market Size by Distribution Channel
4.2.1 Global Biosimilar Insulin Market Size Overview by Distribution Channel (2018-2034)
4.2.2 Global Biosimilar Insulin Historic Market Size Review by Distribution Channel (2018-2024)
4.2.3 Global Biosimilar Insulin Forecasted Market Size by Distribution Channel (2024-2034)
4.3 Key Regions Market Size Segment by Distribution Channel
4.3.1 North America Biosimilar Insulin Sales Breakdown by Distribution Channel (2018-2024)
4.3.2 Europe Biosimilar Insulin Sales Breakdown by Distribution Channel (2018-2024)
4.3.3 Asia-Pacific Biosimilar Insulin Sales Breakdown by Distribution Channel (2018-2024)
4.3.4 Latin America Biosimilar Insulin Sales Breakdown by Distribution Channel (2018-2024)
4.3.5 Middle East and Africa Biosimilar Insulin Sales Breakdown by Distribution Channel (2018-2024)
5 North America Biosimilar Insulin by Country
5.1 North America Biosimilar Insulin Historic Market Size by Country
5.1.1 North America Biosimilar Insulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Biosimilar Insulin Sales in Volume by Country (2018-2024)
5.1.3 North America Biosimilar Insulin Sales in Value by Country (2018-2024)
5.2 North America Biosimilar Insulin Forecasted Market Size by Country
5.2.1 North America Biosimilar Insulin Sales in Volume by Country (2024-2034)
5.2.2 North America Biosimilar Insulin Sales in Value by Country (2024-2034)
6 Europe Biosimilar Insulin by Country
6.1 Europe Biosimilar Insulin Historic Market Size by Country
6.1.1 Europe Biosimilar Insulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Biosimilar Insulin Sales in Volume by Country (2018-2024)
6.1.3 Europe Biosimilar Insulin Sales in Value by Country (2018-2024)
6.2 Europe Biosimilar Insulin Forecasted Market Size by Country
6.2.1 Europe Biosimilar Insulin Sales in Volume by Country (2024-2034)
6.2.2 Europe Biosimilar Insulin Sales in Value by Country (2024-2034)
7 Asia-Pacific Biosimilar Insulin by Region
7.1 Asia-Pacific Biosimilar Insulin Historic Market Size by Region
7.1.1 Asia-Pacific Biosimilar Insulin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Biosimilar Insulin Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Biosimilar Insulin Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Biosimilar Insulin Forecasted Market Size by Region
7.2.1 Asia-Pacific Biosimilar Insulin Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Biosimilar Insulin Sales in Value by Region (2024-2034)
8 Latin America Biosimilar Insulin by Country
8.1 Latin America Biosimilar Insulin Historic Market Size by Country
8.1.1 Latin America Biosimilar Insulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Biosimilar Insulin Sales in Volume by Country (2018-2024)
8.1.3 Latin America Biosimilar Insulin Sales in Value by Country (2018-2024)
8.2 Latin America Biosimilar Insulin Forecasted Market Size by Country
8.2.1 Latin America Biosimilar Insulin Sales in Volume by Country (2024-2034)
8.2.2 Latin America Biosimilar Insulin Sales in Value by Country (2024-2034)
9 Middle East and Africa Biosimilar Insulin by Country
9.1 Middle East and Africa Biosimilar Insulin Historic Market Size by Country
9.1.1 Middle East and Africa Biosimilar Insulin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Biosimilar Insulin Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Biosimilar Insulin Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Biosimilar Insulin Forecasted Market Size by Country
9.2.1 Middle East and Africa Biosimilar Insulin Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Biosimilar Insulin Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Eli Lilly
10.1.1 Eli Lilly Company Information
10.1.2 Eli Lilly Introduction and Business Overview
10.1.3 Eli Lilly Biosimilar Insulin Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Eli Lilly Biosimilar Insulin Products Offered
10.1.5 Eli Lilly Recent Development
10.2 Sanofi
10.2.1 Sanofi Company Information
10.2.2 Sanofi Introduction and Business Overview
10.2.3 Sanofi Biosimilar Insulin Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Sanofi Biosimilar Insulin Products Offered
10.2.5 Sanofi Recent Development
10.3 Gan&Lee
10.3.1 Gan&Lee Company Information
10.3.2 Gan&Lee Introduction and Business Overview
10.3.3 Gan&Lee Biosimilar Insulin Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Gan&Lee Biosimilar Insulin Products Offered
10.3.5 Gan&Lee Recent Development
10.4 Tonghua Dongbao
10.4.1 Tonghua Dongbao Company Information
10.4.2 Tonghua Dongbao Introduction and Business Overview
10.4.3 Tonghua Dongbao Biosimilar Insulin Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Tonghua Dongbao Biosimilar Insulin Products Offered
10.4.5 Tonghua Dongbao Recent Development
10.5 United Laboratory
10.5.1 United Laboratory Company Information
10.5.2 United Laboratory Introduction and Business Overview
10.5.3 United Laboratory Biosimilar Insulin Sales, Revenue and Gross Margin (2018-2024)
10.5.4 United Laboratory Biosimilar Insulin Products Offered
10.5.5 United Laboratory Recent Development
10.6 Geropharm
10.6.1 Geropharm Company Information
10.6.2 Geropharm Introduction and Business Overview
10.6.3 Geropharm Biosimilar Insulin Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Geropharm Biosimilar Insulin Products Offered
10.6.5 Geropharm Recent Development
10.7 Biocon
10.7.1 Biocon Company Information
10.7.2 Biocon Introduction and Business Overview
10.7.3 Biocon Biosimilar Insulin Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Biocon Biosimilar Insulin Products Offered
10.7.5 Biocon Recent Development
10.8 Wockhardt
10.8.1 Wockhardt Company Information
10.8.2 Wockhardt Introduction and Business Overview
10.8.3 Wockhardt Biosimilar Insulin Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Wockhardt Biosimilar Insulin Products Offered
10.8.5 Wockhardt Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Biosimilar Insulin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Biosimilar Insulin Industrial Chain Analysis
11.4 Biosimilar Insulin Market Dynamics
11.4.1 Biosimilar Insulin Industry Trends
11.4.2 Biosimilar Insulin Market Drivers
11.4.3 Biosimilar Insulin Market Challenges
11.4.4 Biosimilar Insulin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Biosimilar Insulin Distributors
12.3 Biosimilar Insulin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Biosimilar Insulin Glargine
Table 2. Major Company of Biosimilar Insulin Lispro
Table 3. Major Company of Other
Table 4. Global Biosimilar Insulin Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Biosimilar Insulin Sales by Type (2018-2024) & (K Unit)
Table 6. Global Biosimilar Insulin Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Biosimilar Insulin Sales by Type (2018-2024) & (US& Million)
Table 8. Global Biosimilar Insulin Market Share in Value by Type (2018-2024)
Table 9. Global Biosimilar Insulin Price by Type (2018-2024) & (US$/Unit)
Table 10. Global Biosimilar Insulin Sales by Type (2024-2034) & (K Unit)
Table 11. Global Biosimilar Insulin Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Biosimilar Insulin Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Biosimilar Insulin Sales Market Share in Value by Type (2024-2034)
Table 14. Global Biosimilar Insulin Price by Type (2024-2034) & (US$/Unit)
Table 15. North America Biosimilar Insulin Sales by Type (2018-2024) & (K Unit)
Table 16. North America Biosimilar Insulin Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Biosimilar Insulin Sales (K Unit) by Type (2018-2024)
Table 18. Europe Biosimilar Insulin Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Biosimilar Insulin Sales (K Unit) by Type (2018-2024)
Table 20. Asia-Pacific Biosimilar Insulin Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Biosimilar Insulin Sales (K Unit) by Type (2018-2024)
Table 22. Latin America Biosimilar Insulin Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Biosimilar Insulin Sales (K Unit) by Type (2018-2024)
Table 24. Middle East and Africa Biosimilar Insulin Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Biosimilar Insulin Sales by Company (2018-2024) & (K Unit)
Table 26. Global Biosimilar Insulin Sales Share by Company (2018-2024)
Table 27. Global Biosimilar Insulin Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Biosimilar Insulin Revenue Share by Company (2018-2024)
Table 29. Global Market Biosimilar Insulin Price by Company (2018-2024) & (US$/Unit)
Table 30. Global Biosimilar Insulin Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Biosimilar Insulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biosimilar Insulin as of 2022)
Table 33. Date of Key Manufacturers Enter into Biosimilar Insulin Market
Table 34. Key Manufacturers Biosimilar Insulin Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Biosimilar Insulin Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Biosimilar Insulin Sales by Region (2018-2024) & (K Unit)
Table 38. Global Biosimilar Insulin Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Biosimilar Insulin Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Biosimilar Insulin Sales Market Share in Value by Region (2018-2024)
Table 41. Global Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 42. Global Biosimilar Insulin Sales by Region (2024-2034) & (K Unit)
Table 43. Global Biosimilar Insulin Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Biosimilar Insulin Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Biosimilar Insulin Sales Market Share in Value by Region (2024-2034)
Table 46. Global Biosimilar Insulin Sales (K Unit), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 47. Global Biosimilar Insulin Sales by Distribution Channel: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Biosimilar Insulin Sales by Distribution Channel (2018-2024) & (K Unit)
Table 49. Global Biosimilar Insulin Sales Market Share in Volume by Distribution Channel (2018-2024)
Table 50. Global Biosimilar Insulin Sales by Distribution Channel (2018-2024) & (US$ Million)
Table 51. Global Biosimilar Insulin Sales Market Share in Value by Distribution Channel (2018-2024)
Table 52. Global Biosimilar Insulin Price by Distribution Channel (2018-2024) & (US$/Unit)
Table 53. Global Biosimilar Insulin Sales by Distribution Channel (2024-2034) & (K Unit)
Table 54. Global Biosimilar Insulin Sales Market Share in Volume by Distribution Channel (2024-2034)
Table 55. Global Biosimilar Insulin Sales by Distribution Channel (2024-2034) & (US$ Million)
Table 56. Global Biosimilar Insulin Sales Market Share in Value by Distribution Channel (2024-2034)
Table 57. Global Biosimilar Insulin Price by Distribution Channel (2024-2034) & (US$/Unit)
Table 58. North America Biosimilar Insulin Sales by Distribution Channel (2018-2024) (K Unit)
Table 59. North America Biosimilar Insulin Sales by Distribution Channel (2018-2024) & (US$ Million)
Table 60. Europe Biosimilar Insulin Sales by Distribution Channel (2018-2024) (K Unit)
Table 61. Europe Biosimilar Insulin Sales by Distribution Channel (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Biosimilar Insulin Sales by Distribution Channel (2018-2024) (K Unit)
Table 63. Asia-Pacific Biosimilar Insulin Sales by Distribution Channel (2018-2024) & (US$ Million)
Table 64. Latin America Biosimilar Insulin Sales by Distribution Channel (2018-2024) (K Unit)
Table 65. Latin America Biosimilar Insulin Sales by Distribution Channel (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Biosimilar Insulin Sales by Distribution Channel (2018-2024) (K Unit)
Table 67. Middle East and Africa Biosimilar Insulin Sales by Distribution Channel (2018-2024) & (US$ Million)
Table 68. North America Biosimilar Insulin Sales by Country (2018-2024) & (K Unit)
Table 69. North America Biosimilar Insulin Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Biosimilar Insulin Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Biosimilar Insulin Sales Market Share in Value by Country (2018-2024)
Table 72. North America Biosimilar Insulin Sales by Country (2024-2034) & (K Unit)
Table 73. North America Biosimilar Insulin Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Biosimilar Insulin Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Biosimilar Insulin Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Biosimilar Insulin Sales by Country (2018-2024) & (K Unit)
Table 77. Europe Biosimilar Insulin Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Biosimilar Insulin Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Biosimilar Insulin Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Biosimilar Insulin Sales by Country (2024-2034) & (K Unit)
Table 81. Europe Biosimilar Insulin Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Biosimilar Insulin Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Biosimilar Insulin Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Biosimilar Insulin Sales by Region (2018-2024) & (K Unit)
Table 85. Asia-Pacific Biosimilar Insulin Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Biosimilar Insulin Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Biosimilar Insulin Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Biosimilar Insulin Sales by Region (2024-2034) & (K Unit)
Table 89. Asia-Pacific Biosimilar Insulin Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Biosimilar Insulin Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Biosimilar Insulin Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Biosimilar Insulin Sales by Country (2018-2024) & (K Unit)
Table 93. Latin America Biosimilar Insulin Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Biosimilar Insulin Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Biosimilar Insulin Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Biosimilar Insulin Sales by Country (2024-2034) & (K Unit)
Table 97. Latin America Biosimilar Insulin Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Biosimilar Insulin Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Biosimilar Insulin Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Biosimilar Insulin Sales by Country (2018-2024) & (K Unit)
Table 101. Middle East and Africa Biosimilar Insulin Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Biosimilar Insulin Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Biosimilar Insulin Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Biosimilar Insulin Sales by Country (2024-2034) & (K Unit)
Table 105. Middle East and Africa Biosimilar Insulin Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Biosimilar Insulin Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Biosimilar Insulin Sales Market Share in Value by Country (2024-2034)
Table 108. Eli Lilly Company Information
Table 109. Eli Lilly Introduction and Business Overview
Table 110. Eli Lilly Biosimilar Insulin Sales (K Unit), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Eli Lilly Biosimilar Insulin Product
Table 112. Eli Lilly Recent Development
Table 113. Sanofi Company Information
Table 114. Sanofi Introduction and Business Overview
Table 115. Sanofi Biosimilar Insulin Sales (K Unit), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Sanofi Biosimilar Insulin Product
Table 117. Sanofi Recent Development
Table 118. Gan&Lee Company Information
Table 119. Gan&Lee Introduction and Business Overview
Table 120. Gan&Lee Biosimilar Insulin Sales (K Unit), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Gan&Lee Biosimilar Insulin Product
Table 122. Gan&Lee Recent Development
Table 123. Tonghua Dongbao Company Information
Table 124. Tonghua Dongbao Introduction and Business Overview
Table 125. Tonghua Dongbao Biosimilar Insulin Sales (K Unit), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. Tonghua Dongbao Biosimilar Insulin Product
Table 127. Tonghua Dongbao Recent Development
Table 128. United Laboratory Company Information
Table 129. United Laboratory Introduction and Business Overview
Table 130. United Laboratory Biosimilar Insulin Sales (K Unit), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. United Laboratory Biosimilar Insulin Product
Table 132. United Laboratory Recent Development
Table 133. Geropharm Company Information
Table 134. Geropharm Introduction and Business Overview
Table 135. Geropharm Biosimilar Insulin Sales (K Unit), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Geropharm Biosimilar Insulin Product
Table 137. Geropharm Recent Development
Table 138. Biocon Company Information
Table 139. Biocon Introduction and Business Overview
Table 140. Biocon Biosimilar Insulin Sales (K Unit), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Biocon Biosimilar Insulin Product
Table 142. Biocon Recent Development
Table 143. Wockhardt Company Information
Table 144. Wockhardt Introduction and Business Overview
Table 145. Wockhardt Biosimilar Insulin Sales (K Unit), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Wockhardt Biosimilar Insulin Product
Table 147. Wockhardt Recent Development
Table 148. Key Raw Materials Lists
Table 149. Raw Materials Key Suppliers Lists
Table 150. Biosimilar Insulin Market Trends
Table 151. Biosimilar Insulin Market Drivers
Table 152. Biosimilar Insulin Market Challenges
Table 153. Biosimilar Insulin Market Restraints
Table 154. Biosimilar Insulin Distributors List
Table 155. Biosimilar Insulin Downstream Customers
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Biosimilar Insulin Product Picture
Figure 2. Global Biosimilar Insulin Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Biosimilar Insulin Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Biosimilar Insulin Sales Status and Outlook (2018-2034) & (K Unit)
Figure 5. Product Picture of Biosimilar Insulin Glargine
Figure 6. Global Biosimilar Insulin Glargine Sales YoY Growth (2018-2034) & (K Unit)
Figure 7. Product Picture of Biosimilar Insulin Lispro
Figure 8. Global Biosimilar Insulin Lispro Sales YoY Growth (2018-2034) & (K Unit)
Figure 9. Product Picture of Other
Figure 10. Global Other Sales YoY Growth (2018-2034) & (K Unit)
Figure 11. Global Biosimilar Insulin Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Biosimilar Insulin Sales Market Share by Type in 2022 & 2034
Figure 13. North America Biosimilar Insulin Sales Market Share in Volume by Type in 2022
Figure 14. North America Biosimilar Insulin Sales Market Share in Value by Type in 2022
Figure 15. Europe Biosimilar Insulin Sales Market Share in Volume by Type in 2022
Figure 16. Europe Biosimilar Insulin Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Biosimilar Insulin Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Biosimilar Insulin Sales Market Share in Value by Type in 2022
Figure 19. Latin America Biosimilar Insulin Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Biosimilar Insulin Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Biosimilar Insulin Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Biosimilar Insulin Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Biosimilar Insulin Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Biosimilar Insulin Revenue in 2022
Figure 25. Biosimilar Insulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Hospital
Figure 27. Global Hospital Sales YoY Growth (2018-2034) & (K Unit)
Figure 28. Product Picture of Retail Pharmacy
Figure 29. Global Retail Pharmacy Sales YoY Growth (2018-2034) & (K Unit)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2018-2034) & (K Unit)
Figure 32. Global Biosimilar Insulin Sales by Distribution Channel (2018-2034) & (US$ Million)
Figure 33. Global Biosimilar Insulin Sales Market Share by Distribution Channel in 2022 & 2034
Figure 34. North America Biosimilar Insulin Sales Market Share in Volume by Distribution Channel in 2022
Figure 35. North America Biosimilar Insulin Sales Market Share in Value by Distribution Channel in 2022
Figure 36. Europe Biosimilar Insulin Sales Market Share in Volume by Distribution Channel in 2022
Figure 37. Europe Biosimilar Insulin Sales Market Share in Value by Distribution Channel in 2022
Figure 38. Asia-Pacific Biosimilar Insulin Sales Market Share in Volume by Distribution Channel in 2022
Figure 39. Asia-Pacific Biosimilar Insulin Sales Market Share in Value by Distribution Channel in 2022
Figure 40. Latin America Biosimilar Insulin Sales Market Share in Volume by Distribution Channel in 2022
Figure 41. Latin America Biosimilar Insulin Sales Market Share in Value by Distribution Channel in 2022
Figure 42. Middle East and Africa Biosimilar Insulin Sales Market Share in Value by Distribution Channel in 2022
Figure 43. Key Raw Materials Price
Figure 44. Biosimilar Insulin Manufacturing Cost Structure
Figure 45. Biosimilar Insulin Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries